Launches probiotic “DSS”, the original De Simone formulation - Alkem Laboratories Ltd

Code BSE: 539523 NSE:

Alkem Laboratories Limited launches probiotic , the original De Simone formulation, in India for gut health management. Developed by Prof. Claudio De Simone, this proprietary probiotic combines eight carefully selected bacterial strains in precise proportions, chosen for their distinct biochemical and enzymatic profile, to act synergistically on the physiology of the gastrointestinal system. The De Simone formulation is recognised as one of the world’s most extensively researched probiotics, backed by over 80 clinical trials and 200 publications over the last two decades. It is also endorsed by leading American and European gastroenterology associations in their guidelines for managing gastrointestinal disorders. Alkem has in-licensed these f frmulations from Next Gen Pharma India Pvt. Ltd